• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学整合分析揭示 ZZZ3/CD70 轴是一个超级增强子驱动的弥漫性大 B 细胞淋巴瘤细胞与自然杀伤细胞相互作用的调控因子。

Integrated multi-omics profiling reveals the ZZZ3/CD70 axis is a super-enhancer-driven regulator of diffuse large B-cell lymphoma cell-natural killer cell interactions.

机构信息

Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

出版信息

Exp Biol Med (Maywood). 2024 Sep 23;249:10155. doi: 10.3389/ebm.2024.10155. eCollection 2024.

DOI:10.3389/ebm.2024.10155
PMID:39376717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11457841/
Abstract

Tumor immune microenvironment is crucial for diffuse large B-cell lymphoma (DLBCL) development. However, the mechanisms by which super-enhancers (SEs) regulate the interactions between DLBCL cells and tumor-infiltrating immune cells remains largely unknown. This study aimed to investigate the role of SE-controlled genes in regulating the interactions between DLBCL cells and tumor-infiltrating immune cells. Single-cell RNA-seq, bulk RNA-seq and H3K27ac ChIP-seq data were downloaded from the Heidelberg Open Research Data database and Gene Expression Omnibus database. HOMER algorithm and Seurat package in R were used for bioinformatics analysis. Cell proliferation and lactate dehydrogenase (LDH) release was detected by MTS and LDH release assays, respectively. Interaction between B cell cluster and CD8 T cell and NK cell cluster was most obviously enhanced in DLBCL, with CD70-CD27, MIF-CD74/CXCR2 complex, MIF-CD74/CD44 complex and CCL3-CCR5 interactions were significantly increased. NK cell sub-cluster showed the strongest interaction with B cell cluster. ZZZ3 upregulated the transcription of by binding to its SE. Silencing CD70 in DOHH2 cells significantly promoted the proliferation of co-cultured NK92 cells and LDH release from DOHH2 cells, which was counteracted by ZZZ3 overexpression in DOHH2 cells. CD70 silencing combined with PD-L1 blockade promoted LDH release from DOHH2 cells co-cultured with NK92 cells. In conclusion, DLBCL cells inhibited the proliferation and killing of infiltrating NK cells by regulating ZZZ3/CD70 axis. Targeting ZZZ3/CD70 axis combined with PD-L1 blockade is expected to be a promising strategy for DLBCL treatment.

摘要

肿瘤免疫微环境对弥漫性大 B 细胞淋巴瘤(DLBCL)的发展至关重要。然而,超增强子(SEs)调控 DLBCL 细胞与肿瘤浸润免疫细胞相互作用的机制在很大程度上尚不清楚。本研究旨在探讨 SE 调控基因在调控 DLBCL 细胞与肿瘤浸润免疫细胞相互作用中的作用。从海德堡开放研究数据数据库和基因表达综合数据库下载单细胞 RNA-seq、批量 RNA-seq 和 H3K27ac ChIP-seq 数据。使用 HOMER 算法和 R 中的 Seurat 包进行生物信息学分析。通过 MTS 和 LDH 释放测定分别检测细胞增殖和乳酸脱氢酶(LDH)释放。在 DLBCL 中,B 细胞簇与 CD8 T 细胞和 NK 细胞簇之间的相互作用最明显增强,CD70-CD27、MIF-CD74/CXCR2 复合物、MIF-CD74/CD44 复合物和 CCL3-CCR5 相互作用明显增加。NK 细胞亚群与 B 细胞簇的相互作用最强。ZZZ3 通过与 SE 结合上调的转录。在 DOHH2 细胞中沉默 CD70 显著促进共培养的 NK92 细胞的增殖和 DOHH2 细胞中 LDH 的释放,而 DOHH2 细胞中 ZZZ3 的过表达则拮抗了这一作用。CD70 沉默联合 PD-L1 阻断促进了与 NK92 细胞共培养的 DOHH2 细胞中 LDH 的释放。综上所述,DLBCL 细胞通过调节 ZZZ3/CD70 轴抑制浸润 NK 细胞的增殖和杀伤。靶向 ZZZ3/CD70 轴联合 PD-L1 阻断有望成为治疗 DLBCL 的一种有前途的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/06e464a88edb/ebm-249-10155-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/6cdc9dd97cc3/ebm-249-10155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/03e9bdb9bc52/ebm-249-10155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/79c2701429ae/ebm-249-10155-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/65befca05f06/ebm-249-10155-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/5a7c456d4d2c/ebm-249-10155-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/9f36419c07f1/ebm-249-10155-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/8d455a2cc728/ebm-249-10155-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/06e464a88edb/ebm-249-10155-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/6cdc9dd97cc3/ebm-249-10155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/03e9bdb9bc52/ebm-249-10155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/79c2701429ae/ebm-249-10155-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/65befca05f06/ebm-249-10155-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/5a7c456d4d2c/ebm-249-10155-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/9f36419c07f1/ebm-249-10155-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/8d455a2cc728/ebm-249-10155-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/11457841/06e464a88edb/ebm-249-10155-g008.jpg

相似文献

1
Integrated multi-omics profiling reveals the ZZZ3/CD70 axis is a super-enhancer-driven regulator of diffuse large B-cell lymphoma cell-natural killer cell interactions.多组学整合分析揭示 ZZZ3/CD70 轴是一个超级增强子驱动的弥漫性大 B 细胞淋巴瘤细胞与自然杀伤细胞相互作用的调控因子。
Exp Biol Med (Maywood). 2024 Sep 23;249:10155. doi: 10.3389/ebm.2024.10155. eCollection 2024.
2
The dual role of CD70 in B-cell lymphomagenesis.CD70 在 B 细胞淋巴瘤发生中的双重作用。
Clin Transl Med. 2022 Dec;12(12):e1118. doi: 10.1002/ctm2.1118.
3
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.CD70 反向信号增强了表达 CD27 的 B 细胞恶性肿瘤中 NK 细胞的功能和免疫监视。
Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.
4
LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.长链非编码 RNA MALAT1 通过海绵吸附 miR-195 促进弥漫性大 B 细胞淋巴瘤的发生和免疫逃逸。
Life Sci. 2019 Aug 15;231:116335. doi: 10.1016/j.lfs.2019.03.040. Epub 2019 Mar 18.
5
Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis.综合分析鉴定生发中心 B 细胞型弥漫性大 B 细胞淋巴瘤预后相关超级增强子关键基因。
BMC Med Genomics. 2021 Mar 4;14(1):69. doi: 10.1186/s12920-021-00916-z.
6
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.免疫分析和定量分析解析免疫检查点表达在 DLBCL 肿瘤免疫微环境中的临床作用。
Cancer Immunol Res. 2019 Apr;7(4):644-657. doi: 10.1158/2326-6066.CIR-18-0439. Epub 2019 Feb 11.
7
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.可溶性 CD27 在结外鼻型自然杀伤/T 细胞淋巴瘤中的表达:作为诊断和 CD27/CD70 靶向治疗的潜在生物标志物。
Cancer Immunol Immunother. 2023 Jul;72(7):2087-2098. doi: 10.1007/s00262-023-03394-7. Epub 2023 Feb 22.
8
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.PD-1/PD-L1 在肿瘤微环境和肿瘤细胞中表达对淋巴瘤的预后和临床病理意义。
Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6.
9
Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.全面分析 CD70-CD27 信号轴在泛癌中的预后和免疫功能。
Funct Integr Genomics. 2023 Jan 26;23(1):48. doi: 10.1007/s10142-023-00977-6.
10
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.miR155 通过 PD-1/PD-L1 介导的淋巴瘤细胞与 CD8+T 细胞相互作用使 B 细胞淋巴瘤细胞对抗 PD-L1 抗体敏感。
Mol Cancer. 2019 Mar 30;18(1):54. doi: 10.1186/s12943-019-0977-3.

本文引用的文献

1
Single-cell RNA sequencing of intestinal crypts reveals vital events in damage repair and the double-edged sword effect of the Wnt3/β-catenin pathway in irradiated mice.肠道隐窝的单细胞 RNA 测序揭示了辐射损伤修复中的重要事件和 Wnt3/β-catenin 通路的双刃剑效应。
Redox Biol. 2023 Dec;68:102942. doi: 10.1016/j.redox.2023.102942. Epub 2023 Oct 25.
2
Macrophages Promote Tumor Cell Extravasation across an Endothelial Barrier through Thin Membranous Connections.巨噬细胞通过薄的膜状连接促进肿瘤细胞穿过内皮屏障外渗。
Cancers (Basel). 2023 Mar 31;15(7):2092. doi: 10.3390/cancers15072092.
3
Cistrome Explorer: an interactive visual analysis tool for large-scale epigenomic data.
Cistrome Explorer:用于大规模表观基因组数据的交互式可视化分析工具。
Bioinformatics. 2023 Feb 3;39(2). doi: 10.1093/bioinformatics/btad018.
4
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.肿瘤微环境中的亲密通讯:基质因素作为一个管弦乐队发挥作用。
J Biomed Sci. 2023 Jan 4;30(1):1. doi: 10.1186/s12929-022-00894-z.
5
The dual role of CD70 in B-cell lymphomagenesis.CD70 在 B 细胞淋巴瘤发生中的双重作用。
Clin Transl Med. 2022 Dec;12(12):e1118. doi: 10.1002/ctm2.1118.
6
CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data.CellMarker 2.0:一个更新的数据库,包含基于 scRNA-seq 数据的人类/小鼠细胞标志物的人工注释和网络工具。
Nucleic Acids Res. 2023 Jan 6;51(D1):D870-D876. doi: 10.1093/nar/gkac947.
7
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.癌症免疫治疗时代胰腺导管腺癌的表观遗传调控。
J Gastroenterol. 2022 Nov;57(11):819-826. doi: 10.1007/s00535-022-01915-2. Epub 2022 Sep 1.
8
CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy.CD137L 和 CD4 T 细胞限制 BCL6 表达的生发中心前 B 细胞扩增和 BCL6 驱动的 B 细胞恶性肿瘤。
Immunol Cell Biol. 2022 Oct;100(9):705-717. doi: 10.1111/imcb.12578. Epub 2022 Aug 17.
9
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.超级增强子突变改变了 B 细胞淋巴瘤中的癌基因表达。
Nature. 2022 Jul;607(7920):808-815. doi: 10.1038/s41586-022-04906-8. Epub 2022 Jul 6.
10
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.一种用于预测弥漫性大B细胞淋巴瘤患者预后的新型定义的超级增强子相关基因特征。
Front Genet. 2022 Jun 14;13:827840. doi: 10.3389/fgene.2022.827840. eCollection 2022.